Antitumor Agents 295. E-ring Hydroxylated Antofine and Cryptopleurine Analogues As Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies.

Xiaoming Yang,Qian Shi,Chin-Yu Lai,Chi-Yuan Chen,Emika Ohkoshi,Shuenn-Chen Yang,Chih-Ya Wang,Kenneth F. Bastow,Tian-Shung Wu,Shiow-Lin Pan,Che-Ming Teng,Pan-Chyr Yang,Kuo-Hsiung Lee
DOI: https://doi.org/10.1021/jm3001218
2012-01-01
Abstract:Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.
What problem does this paper attempt to address?